"European development programs"

#6312596

31 Dec 2020

Ariane V space rocket with boosters standing. Full-scale model demonstration of Ariane 5 launcher space technology, ESA EADS Ariane space rocket in Le Bourget Air and Space Museum in Paris during the 53rd Paris Air Show Salon international de l'aéronautique et de l'espace de Paris-Le Bourget, Salon du Bourget. Ariane 5 is a European heavy-lift space launch vehicle developed and operated by Arianespace for the European Space Agency (ESA) used to deliver payloads into geostationary transfer orbit (GTO) or low Earth orbit (LEO) made by the Airbus Defence and Space manufacturer. Paris, France on June 21, 2019

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6312598

31 Dec 2020

Ariane V space rocket with boosters standing. Full-scale model demonstration of Ariane 5 launcher space technology, ESA EADS Ariane space rocket in Le Bourget Air and Space Museum in Paris during the 53rd Paris Air Show Salon international de l'aéronautique et de l'espace de Paris-Le Bourget, Salon du Bourget. Ariane 5 is a European heavy-lift space launch vehicle developed and operated by Arianespace for the European Space Agency (ESA) used to deliver payloads into geostationary transfer orbit (GTO) or low Earth orbit (LEO) made by the Airbus Defence and Space manufacturer. Paris, France on June 21, 2019

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6312600

31 Dec 2020

Ariane V space rocket with boosters standing. Full-scale model demonstration of Ariane 5 launcher space technology, ESA EADS Ariane space rocket in Le Bourget Air and Space Museum in Paris during the 53rd Paris Air Show Salon international de l'aéronautique et de l'espace de Paris-Le Bourget, Salon du Bourget. Ariane 5 is a European heavy-lift space launch vehicle developed and operated by Arianespace for the European Space Agency (ESA) used to deliver payloads into geostationary transfer orbit (GTO) or low Earth orbit (LEO) made by the Airbus Defence and Space manufacturer. Paris, France on June 21, 2019

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6312602

31 Dec 2020

Ariane V space rocket with boosters standing. Full-scale model demonstration of Ariane 5 launcher space technology, ESA EADS Ariane space rocket in Le Bourget Air and Space Museum in Paris during the 53rd Paris Air Show Salon international de l'aéronautique et de l'espace de Paris-Le Bourget, Salon du Bourget. Ariane 5 is a European heavy-lift space launch vehicle developed and operated by Arianespace for the European Space Agency (ESA) used to deliver payloads into geostationary transfer orbit (GTO) or low Earth orbit (LEO) made by the Airbus Defence and Space manufacturer. Paris, France on June 21, 2019

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6312604

31 Dec 2020

Ariane V space rocket with boosters standing. Full-scale model demonstration of Ariane 5 launcher space technology, ESA EADS Ariane space rocket in Le Bourget Air and Space Museum in Paris during the 53rd Paris Air Show Salon international de l'aéronautique et de l'espace de Paris-Le Bourget, Salon du Bourget. Ariane 5 is a European heavy-lift space launch vehicle developed and operated by Arianespace for the European Space Agency (ESA) used to deliver payloads into geostationary transfer orbit (GTO) or low Earth orbit (LEO) made by the Airbus Defence and Space manufacturer. Paris, France on June 21, 2019

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6312606

31 Dec 2020

Ariane V space rocket with boosters standing. Full-scale model demonstration of Ariane 5 launcher space technology, ESA EADS Ariane space rocket in Le Bourget Air and Space Museum in Paris during the 53rd Paris Air Show Salon international de l'aéronautique et de l'espace de Paris-Le Bourget, Salon du Bourget. Ariane 5 is a European heavy-lift space launch vehicle developed and operated by Arianespace for the European Space Agency (ESA) used to deliver payloads into geostationary transfer orbit (GTO) or low Earth orbit (LEO) made by the Airbus Defence and Space manufacturer. Paris, France on June 21, 2019

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274256

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274258

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274260

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274262

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274264

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274266

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274270

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274272

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274274

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274276

14 Dec 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.